✦ LIBER ✦

A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis

✍ Scribed by Markus W. Rudolph; Sandra Klein; Thomas E. Beckert; Hans-Ulrich Petereit; Jennifer B. Dressman

Book ID: 117639199
Publisher: Elsevier Science
Year: 2001
Tongue: French
Weight: 687 KB
Volume: 51
Category: Article
ISSN: 0939-6411
DOI: 10.1016/s0939-6411(01)00134-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of persistence with 5-aminosa

Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis

✍ S. V. KANE; N. A. ACCORTT; S. MAGOWAN; D. BRIXNER 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Effect of weekend 5-aminosalicylic acid

Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a randomized controlled study

✍ Hiroshi Yokoyama; Sho Takagi; Shinichi Kuriyama; Shuichiro Takahashi; Hiroki Tak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Background: 5-Aminosalicylic acid (5-ASA) is known to be effective in the treatment of active ulcerative colitis (UC). The aim of the current study was to investigate the effect of 5-ASA enemas, as a maintenance therapy for UC, when administered twice weekly as a weekend treatment regimen, compared

Cytoprotection against neutrophil derive

Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis.

✍ Dallegri, F; Ottonello, L; Ballestrero, A; Bogliolo, F; Ferrando, F; Patrone, F 📂 Article 📅 1990 🏛 BMJ Publishing Group 🌐 English ⚖ 578 KB

T1136 Once-Daily MMX® 5-Aminosalicylic A

T1136 Once-Daily MMX® 5-Aminosalicylic Acid Versus Twice-Daily Asacol® for the Maintenance of Remission of Ulcerative Colitis: A Preliminary Analysis

✍ Prantera, Cosimo; Kohn, Anna; Campieri, M.; Caprilli, Renzo; Sturniolo, Giacomo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Trial of trefoil factor 3 enemas, in com

Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis

✍ A. Mahmood; L. Melley; A. J. Fitzgerald; S. Ghosh; R. J. Playford 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

T1151 Once-Daily MMX® 5-Aminosalicylic A

T1151 Once-Daily MMX® 5-Aminosalicylic Acid (2.4g/Day) Has a Similar Safety Profile to Twice-Daily Asacol® Delayed-Release Tablets (2.4g/Day): Results of a Superiority Trial for the Maintenance of Remission of Ulcerative Colitis

✍ Prantera, Cosimo; Scribano, M.L.; Franchini, Stefano; Bellinvia, Salvatore 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 103 KB